Karen M. Soares - 13 Sep 2024 Form 4/A - Amendment Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Signature
/s/Peter J. Rivas as attorney-in-fact for Karen M. Soares
Issuer symbol
CLOV
Transactions as of
13 Sep 2024
Net transactions value
-$110,069
Form type
4/A - Amendment
Filing time
04 Aug 2025, 17:07:07 UTC
Date Of Original Report
17 Sep 2024
Previous filing
16 Aug 2024
Next filing
17 Oct 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Soares Karen General Counsel & Secretary C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON /s/Peter J. Rivas as attorney-in-fact for Karen M. Soares 04 Aug 2025 0001999086

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +518,000 +52% $0.000000 1,515,032 13 Sep 2024 Direct F1
transaction CLOV Class A Common Stock Tax liability $110,069 -38,086 -2.5% $2.89 1,476,946 31 Jul 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. This Amendment is being filed to reflect the full number of RSUs that were achieved.
F2 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.
F3 Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through July 31, 2025.